We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
+47.62%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$316M
AUM Growth
+$98.3M
Cap. Flow
+$26.8M
Cap. Flow %
8.48%
Top 10 Hldgs %
98.37%
Holding
19
New
4
Increased
Reduced
2
Closed
4

Sector Composition

Rank Sector Weight
1 Real Estate 13.85%
2 Healthcare 8.61%
3 Financials 2.61%
4 Technology 0.37%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
$185M 58.62%
2,358,084
CSGP icon
2
CoStar Group
CSGP
$11.7B
$39.5M 12.51%
1,906,370
-44,800
-2% -$910K
UUP icon
3
PUT
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
$25.6M 8.1%
+985,100
New +$25.7M
IBRX icon
4
ImmunityBio
IBRX
$7.51B
$15.9M 5.04%
4,485,495
SRNE
5
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$11.1M 3.5%
2,799,790
MDXG icon
6
MiMedx Group
MDXG
$602M
$10.3M 3.26%
1,080,365
LPLA icon
7
LPL Financial
LPLA
$28.3B
$8.23M 2.61%
206,647
EMB icon
8
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$7.9M 2.5%
+70,000
New +$7.88M
UNIT
9
Uniti Group
UNIT
$2.36B
$4.21M 1.33%
163,000
OEF icon
10
CALL
iShares S&P 100 ETF
OEF
$20.1B
$2.8M 0.89%
9,560
-840
-8% -$86.7K
FXY icon
11
Invesco CurrencyShares Japanese Yen Trust
FXY
$438M
$2.7M 0.86%
+31,245
New +$2.65M
NH
12
DELISTED
NantHealth, Inc
NH
$1.18M 0.38%
15,922
EDIT icon
13
Editas Medicine
EDIT
$396M
$922K 0.29%
41,324
TSLA icon
14
PUT
Tesla
TSLA
$1.23T
$306K 0.1%
+16,500
New +$279K
ADVM
15
DELISTED
Adverum Biotechnologies
ADVM
$41K 0.01%
1,500
GM icon
16
General Motors
GM
$80.4B
-800
Closed -$28K
IBB icon
17
iShares Biotechnology ETF
IBB
$9.34B
-5,157
Closed -$456K
NTLA icon
18
Intellia Therapeutics
NTLA
$1.49B
-3,542
Closed -$46K
VXX
19
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
-80,150
Closed -$8.18M

Similar funds

Wildcat Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Wildcat Capital Management held 19 positions worth $316M, up 45% from $217M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Wildcat Capital Management deployed $26.8M of net new capital in Q1 2017, opening 4 new positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 70,000 shares worth $7.9M.

By sector, the portfolio is most concentrated in Real Estate at 14% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CoStar Group, an estimated $910K trimmed.

  • Wildcat Capital Management's largest Q1 2017 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 70,000 shares worth $7.9M.
  • Wildcat Capital Management's biggest Q1 2017 reduction was CoStar Group, cutting an estimated $910K.
  • Wildcat Capital Management fully exited iShares Biotechnology ETF in Q1 2017, selling an estimated $456K.
  • Wildcat Capital Management's ten largest holdings make up 98% of its $316M portfolio in Q1 2017.
  • Wildcat Capital Management opened 4 new positions and closed 4 in Q1 2017.
  • Wildcat Capital Management's portfolio value rose 45% quarter-over-quarter to $316M.

Based on Wildcat Capital Management's 13F filing for Q1 2017, filed 9 May 2017.